|
|
|
|
LEADER |
05006nam a22004215i 4500 |
001 |
978-1-4612-3508-8 |
005 |
20191024211256.0 |
007 |
cr nn 008mamaa |
008 |
121227s1989 xxu| s |||| 0|eng d |
020 |
|
|
|a 9781461235088
|
024 |
7 |
|
|a 10.1007/978-1-4612-3508-8
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
100 |
1 |
|
|a Talwar, G. P.
|e author.
|
245 |
1 |
0 |
|a Progress in Vaccinology
|c by G. P. Talwar.
|
246 |
3 |
|
|a The papers in this volume were presented at Symposium on Progress in Vaccinology, 1-5 December 1986, New Delhi, India
|
250 |
|
|
|a 1st ed. 1989.
|
260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 1989.
|
300 |
|
|
|a XX, 483 p.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Progress in Vaccinology,
|v 2
|
505 |
0 |
|
|a I Opening Remarks -- 1. Vaccinology: The Two Revolutions -- II Public Health Perspective—The Present Scene -- 2. Vaccinology and the Goal of Health for All -- 3. Toward Universal Immunization: 1990 -- 4. New and Improved Techniques for Vaccine Production -- 5. Transfer of Vaccine Production to the Developing World: Rabies Vaccine -- 6. Policy for Developing Countries for Storage, Distribution, and Use of Essential Vaccines for Immunoprophylaxis -- III Environmental Factors Modulating The Efficacy of The Vaccine -- 7. Immunity in Tuberculosis: Environmental Versus Intrinsic Factors Modulating the Immune Responsiveness to Mycobacteria -- 8. Geographic Variation in Vaccine Efficacy: The Polio Experience -- IV Hepatitis -- 9. Molecular Immunology of Viral Antigens in Hepatitis B Vaccinations -- 10. Biologic Significance of Pre-S Antigen and Anti-Pre-S Antibodies in Hepatitis B Virus Infection -- 11. Enterically Transmitted Hepatitis Viruses: Prospects for Control -- 12. Immunological Characterization of a Viral Agent Involved in Epidemic and Sporadic Non-A Non-B Hepatitis -- V Gastrointestinal Infections -- 13. Attenuated Oral Typhoid Vaccine Ty 21a -- 14. Oral B Subunit—Whole Cell Vaccine Against Cholera: From Basic Research to Successful Field Trial -- 15. Prospects of Immunization Against Cholera by Adhesive Antigen -- 16. Protective Antigens of Vibrio cholerae -- 17. Rationale for the Development of a Rotavirus Vaccine for Infants and Young Children -- 18. Mucosal Immunity in the Gastrointestinal Tract in Relation to ETEC Vaccine Development -- 19. Shigella Vaccines -- 20. DNA Sequence Homology Among Genes of Shigella spp. and Enteroinvasive Escherichia coli.. -- 21. Mucosal and Acquired Immunity in Giardiasis and Its Relation to Diarrhea and Malabsorption -- 22. Immunology of Entamoeba histolytica in Human and Experimental Hosts -- 23. Molecular Comparisons Among Entamoeba histolytica Strains Using DNA and Protein Profiles -- VI Filariasis -- 24. Importance of Antibody Class in Helminth Infections -- 25. Immunodiagnosis of Filariasis -- VII Veterinary Vaccines -- 26. Development, Production, and Application of Vaccines in Foot-and-Mouth Disease Control in India -- 27. Cell Culture Vaccine Against Bovine Tropical Theileriosis -- VIII Leprosy -- 28. Present Approaches to Immunotherapy and Immunoprophylaxis for Leprosy -- 29. Armadillo-Derived Killed M. leprae: Candidate Vaccine Against Leprosy -- 30. Mycobacterium w: Candidate Vaccine Against Leprosy with Antigens Cross-Reactive with Three Major Protein Antigens of Mycobacterium leprae -- 31. Molecular Approaches to Developing a Vaccine for Leprosy, -- 32. Immunodiagnosis of Leprosy -- 33. Immunodiagnostic Approaches to the Detection of M. leprae Infection in Leprosy -- 34. Serological Survey of Leprosy Using a Monoclonal Antibody-Based Immunoassay and Phenolic Glycolipid ELISA -- IX Malaria and Leishmaniasis -- 35. Antisporozoite Malaria Vaccine Development Based on Circumsporozoite Protein -- 36. Malaria Sporozoite Vaccine Development: Recent Progress -- 37. Community-Based Integrated Vector Control of Malaria in India -- 38. Leishmaniasis and Malaria: New Tools for Epidemiological Analysis -- X New Approaches to Vaccinology -- 39. Vaccinia Virus Expression Vectors -- 40. Vaccinia Recombinants Expressing Foreign Antigens: Antiviral and Antitumor Immunity -- 41. Liposomes as Carriers of Vaccines -- 42. A Short Primer on Vaccine Design: Focus on the Interrelatedness of Antigenic Determinants Addressing Various Lymphocyte Sub-populations -- 43. Next Steps in the Evolution of Vaccinology.
|
650 |
|
0 |
|a Life sciences.
|
650 |
|
0 |
|a Hepatology.
|
650 |
|
0 |
|a Gastroenterology .
|
650 |
|
0 |
|a Allergy.
|
650 |
|
0 |
|a Medical microbiology.
|
650 |
|
0 |
|a Immunology.
|
650 |
1 |
4 |
|a Life Sciences, general.
|
650 |
2 |
4 |
|a Hepatology.
|
650 |
2 |
4 |
|a Gastroenterology.
|
650 |
2 |
4 |
|a Allergology.
|
650 |
2 |
4 |
|a Medical Microbiology.
|
650 |
2 |
4 |
|a Immunology.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4612-3508-8
|